Microbiology Testing Market: By Product Type (Instruments, Chemicals & Reagents, Consumables & Accessories, Others), By Application (Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, Bloodstream Infections, Sexually Trasnsmitted Infections, Others), By End-User (Hospital Based Laboratories, Independent Laboratories, Acadamics & Research Institutes, Others) and Geography
Microbiology Testing Market size was valued at USD 3,913.6 Million in 2022 and is poised to grow at a significant CAGR of 10.6% over 2023-2029. Microbiology testing is an analytical technique utilized to determine the number of microorganisms in psoriasis biologicals samples, food, beverages, and environmental samples. The microbiology testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify microbes. The Chemicals & Reagents segment anticipated to grow at significant CAGR over the forecast years owing to the wide range of chemical reagent uses and research activities Constant advancements and development in technologies such as bio-therapeutics, cell culture, and recombinant DNA technology, which have allowed the manufacturers of a wide range of vital therapeutic agents, also fuel the demand for laboratory chemical reagents. Furthermore, rising demand from the biotechnology industry may drive market expansion in the next years. The market for protein synthesis and DNA sequencing reagents has grown considerably in recent years. Technological improvements in microbiology testing, increased occurrences of infectious illnesses and epidemic outbreaks such as COVID 19, rising healthcare spending, and expanding private-public financing for infectious disease research are driving the growth of the microbiology testing market.
Microbiology Testing Market Key Developments:
In February2020, QIAGEN partnered with Nigeria’s National Tuberculosis & Leprosy Control Program (NTBLCP) to adopt the World Health Organization (WHO) guidelines and guide healthcare professionals in dealing with latent TB
In July 2020, bioMérieux launched BIOFIRE MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry. The new BIOFIRE MYCOPLASMA test, which is available in the United States, will be launched in some countries in Europe and the Asia-Pacific region in the coming months.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
According to the WHO, three infectious diseases, including lower respiratory infections, diarrheal diseases, and TB, were among the top 10 causes of mortality globally in 2016. As a result, the increased frequency and incidence of infectious diseases drives the need for microbiological testing, resulting in worldwide market growth. Furthermore, the rising number of COVID-19 cases contributes to the market's expansion. Growing government and private funds and support for research and development further drive the growth of the market. For instance, the Department of Science and Technology (DST), India, announced funding of approximately USD 26.42 million to many scientific institutions, startups, and industries to build innovative solutions to fight the COVID-19 pandemic on 8 April 2020.
North America is anticipated to hold a sizeable market share in the global microbiology testing market due to its strong healthcare infrastructure, growing investments from major players in the development of cutting-edge devices, established distribution channels for manufacturers of clinical microbiology products, and an increase in research activities. Additionally, the Asia-Pacific region is anticipated to expand significantly due to increased government initiatives to increase awareness, an increase in medical tourism, expanding research activities in the region, a favourable regulatory environment to improve the adoption rate of microbiology testing and other advanced diagnostic methods, and rising demand for high-quality healthcare in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.